Gill Riley, who wasn't obese, regrets taking unprescribed weight-loss medication she purchased from a friend 'to be skinny' ...

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...

Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight ...

Roche moved to enter the booming weight-loss drug market now dominated by Novo Nordisk and Eli Lilly. The Swiss ...

Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.

Several weight loss drug stocks are sliding today as pharmaceutical companies battle for dominance in the booming GLP-1 ...

Very few people are currently being prescribed drugs for weight loss on the NHS in Scotland, research by BBC Scotland News ...

New trial data showed CagriSema led to “superior” weight loss, but at a rate much less than original expectations of 25%.

Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate ...

The U.S. Food and Drug Administration said on Monday it will not take action against compounding pharmacies making copies of ...

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...